Non-canonical ubiquitylation: mechanisms and consequences
- PMID: 23732108
- DOI: 10.1016/j.biocel.2013.05.026
Non-canonical ubiquitylation: mechanisms and consequences
Abstract
Post-translational protein modifications initiate, regulate, propagate and terminate a wide variety of processes in cells, and in particular, ubiquitylation targets substrate proteins for degradation, subcellular translocation, cell signaling and multiple other cellular events. Modification of substrate proteins is widely observed to occur via covalent linkages of ubiquitin to the amine groups of lysine side-chains. However, in recent years several new modes of ubiquitin chain attachment have emerged. For instance, covalent modification of non-lysine sites in substrate proteins is theoretically possible according to basic chemical principles underlying the ubiquitylation process, and evidence is building that sites such as the N-terminal amine group of a protein, the hydroxyl group of serine and threonine residues and even the thiol groups of cysteine residues are all employed as sites of ubiquitylation. However, the potential importance of this "non-canonical ubiquitylation" of substrate proteins on sites other than lysine residues has been largely overlooked. This review aims to highlight the unusual features of the process of non-canonical ubiquitylation and the consequences of these events on the activity and fate of a protein.
Keywords: ERAD; HECT; HOMO; LUMO; Non-canonical ubiquitylation; Protein degradation; RING; SCF; SUMO; Skp-Cullin-F-box; UFD; UPS; Ub; Ubiquitin; Ubiquitin ligase; Ubiquitinomics; endoplasmic reticulum-associated degradation; highest occupied molecular orbital; homologous to E6 carboxyl terminus; lowest unoccupied molecular orbital; really Interesting New Gene; small ubiquitin-like modifier; ubiquitin; ubiquitin fusion degradation; ubiquitin proteasome system.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis.J Biol Chem. 2009 Jun 5;284(23):15458-68. doi: 10.1074/jbc.M809366200. Epub 2009 Mar 31. J Biol Chem. 2009. PMID: 19336407 Free PMC article.
-
Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids.Mol Cell. 2010 Dec 22;40(6):917-26. doi: 10.1016/j.molcel.2010.11.033. Mol Cell. 2010. PMID: 21172657 Free PMC article.
-
Thioester and Oxyester Linkages in the Ubiquitin System.Methods Mol Biol. 2023;2602:3-18. doi: 10.1007/978-1-0716-2859-1_1. Methods Mol Biol. 2023. PMID: 36446963 Review.
-
Non-canonical ubiquitin-based signals for proteasomal degradation.J Cell Sci. 2012 Feb 1;125(Pt 3):539-48. doi: 10.1242/jcs.093567. J Cell Sci. 2012. PMID: 22389393 Review.
-
Ube2W conjugates ubiquitin to α-amino groups of protein N-termini.Biochem J. 2013 Jul 1;453(1):137-45. doi: 10.1042/BJ20130244. Biochem J. 2013. PMID: 23560854 Free PMC article.
Cited by
-
The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.J Biol Chem. 2021 Jan-Jun;296:100246. doi: 10.1074/jbc.RA120.015162. Epub 2021 Jan 8. J Biol Chem. 2021. PMID: 33853758 Free PMC article.
-
Advances in aquatic animal RIG-I-like receptors.Fish Shellfish Immunol Rep. 2021 May 21;2:100012. doi: 10.1016/j.fsirep.2021.100012. eCollection 2021 Dec. Fish Shellfish Immunol Rep. 2021. PMID: 36420517 Free PMC article. Review.
-
The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.Clin Transl Med. 2023 Mar;13(3):e1204. doi: 10.1002/ctm2.1204. Clin Transl Med. 2023. PMID: 36881608 Free PMC article. Review.
-
The E3 ligase HOIL-1 catalyses ester bond formation between ubiquitin and components of the Myddosome in mammalian cells.Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13293-13298. doi: 10.1073/pnas.1905873116. Epub 2019 Jun 17. Proc Natl Acad Sci U S A. 2019. PMID: 31209050 Free PMC article.
-
In silico analysis of the profilaggrin sequence indicates alterations in the stability, degradation route, and intracellular protein fate in filaggrin null mutation carriers.Front Mol Biosci. 2023 May 2;10:1105678. doi: 10.3389/fmolb.2023.1105678. eCollection 2023. Front Mol Biosci. 2023. PMID: 37200867 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources